Global Parkinson's Disease Market, By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), Patient Care Setting (Hospitals, Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The Parkinson's disease market is expected to witness market growth at a rate of 7.1% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Parkinson's disease market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the ageing population globally is escalating the growth of Parkinson's disease market.
Parkinson’s disease refers to the combination of progressive, degenerative neurological motor disorder which generally affects the dopaminergic cells of the brain. Some of the common symptoms of the neurological disorder are rigidity, bradykinesia, tremors and postural volatility. The disease is known to affect the patient’s facial expressions, hand & leg movements as worsens with the increase in age.
The rise in the prevalence of Parkinson's disease among population across the globe acts as one of the major factors driving the growth of Parkinson's disease market. The increase in demand for combination treatments that assist in neural transplantation, prolonged action of unremitting dopaminergic stimulation medicines and gene therapy and initiatives by government bodies through the form of funding accelerate the Parkinson's disease market growth. The increase in number of patient visits to the hospital owing to the availability of diagnostic laboratories and rise in usage of L-Dopa, a symptomatic dopamine replacement treatment along with nigrostriatal system further influences the Parkinson's disease market. Additionally, improving healthcare system, growth in population, research and development activities and rise in healthcare expenditure positively affect the Parkinson's disease market. Furthermore, patent expiry of branded drugs and strong drug pipeline extend profitable opportunities to the Parkinson's disease market players in the forecast period of 2021 to 2028.
On the other hand, availability of alternative treatments and the lack of curable drugs are the factors expected to obstruct the Parkinson's disease market growth. The rise in concerns regarding the side effects with the some drugs is projected to challenge the Parkinson's disease market in the forecast period of 2021-2028.
This Parkinson's disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Parkinson's disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Parkinson's Disease Market Scope and Market Size
The Parkinson's disease market is segmented on the basis of drug class, medical devices, route of administration, distribution channel and patient care setting. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the Parkinson's disease market is segmented into levodopa/carbidopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs.
- On the basis of medical devices, the Parkinson's disease market is segmented into deep brain stimulation (DBS) devices and carbidopa/levodopa enteral suspension (duopa) delivery devices.
- On the basis of route of administration, the Parkinson's disease market is segmented into oral, transdermal, subcutaneous, intestinal infusion and others.
- On the basis of distribution channel, the Parkinson's disease market is segmented into hospital pharmacies, clinics, retail pharmacies and online pharmacies.
- On the basis of patient care setting, the Parkinson's disease market is segmented into hospitals and clinics.
Global Parkinson's Disease Market Country Level Analysis
The Parkinson's disease market is analyzed and market size insights and trends are provided by country, drug class, medical devices, route of administration, distribution channel and patient care setting as referenced above.
The countries covered in the global Parkinson's disease market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the Parkinson's disease market due to the increasing occurrence of the disorder and well-developed healthcare infrastructure. Asia-Pacific is expected to witness high growth during the forecast period of 2021-2028 due to the presence of untapped market and supportive government policies in the region.
The country section of the Parkinson's disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Parkinson's disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Parkinson's disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Parkinson's disease market. The data is available for historic period 2011-2019.
Competitive Landscape and Parkinson's Disease Market Share Analysis
The Parkinson's disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Parkinson's disease market.
The major players covered in the Parkinson's disease market report are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Impax Laboratories LLC, AbbVie Inc., Bausch Health, Lundbeck, Sun Pharmaceutical Industries Ltd., ACADIA Pharmaceuticals Inc., Merck & Co. Inc., Novartis AG, UCB S.A., Dr. Reddy’s Laboratories Ltd., WOCKHARDT, F. Hoffmann-La Roche Ltd, STADA Arzneimittel AG, Orion Corporation, Mylan N.V., Cipla Inc., Par Pharmaceutical, DAIICHI SANKYO COMPANY LIMITED and Apotex Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.